Literature DB >> 19969054

Liposomes as delivery systems for antibiotics.

Zuzanna Drulis-Kawa1, Agata Dorotkiewicz-Jach.   

Abstract

Liposomes are currently in common use as universal drug carriers in the cosmetic and pharmaceutical industries. The manipulation of different physicochemical properties of liposomes enables the design of particular carriers with the desired pharmacokinetic and pharmacodynamic properties. Most studies regarding liposomal antibiotics deal with aminoglycosides, quinolones, polypeptides, and betalactames. Some of the studies focused on improving pharmacokinetics and reducing toxicity, while others involved enhancing antibacterial activity. In an era of an avalanche of increasing bacterial resistance and severe problems in treating bacterial infections, the application of liposomal antibiotic carriers could be useful, but the high cost of liposome preparation and treatment should also be considered. 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19969054     DOI: 10.1016/j.ijpharm.2009.11.033

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  49 in total

1.  PEGylated liposome encapsulation increases the lung tissue concentration of vancomycin.

Authors:  Krishna Muppidi; Jeffrey Wang; Guru Betageri; Andrew S Pumerantz
Journal:  Antimicrob Agents Chemother       Date:  2011-07-25       Impact factor: 5.191

2.  Pharmacokinetics and efficacy of liposomal polymyxin B in a murine pneumonia model.

Authors:  Jie He; Kamilia Abdelraouf; Kimberly R Ledesma; Diana S-L Chow; Vincent H Tam
Journal:  Int J Antimicrob Agents       Date:  2013-08-22       Impact factor: 5.283

3.  Liposomes as multicompartmental carriers for multidrug delivery in anticancer chemotherapy.

Authors:  Donato Cosco; Donatella Paolino; Jessica Maiuolo; Diego Russo; Massimo Fresta
Journal:  Drug Deliv Transl Res       Date:  2011-02       Impact factor: 4.617

4.  Fluorescence study of lipid bilayer interactions of Eu(III) coordination complexes.

Authors:  Olga K Kutsenko; Valeriya M Trusova; Galyna P Gorbenko; Todor Deligeorgiev; Aleksey Vasilev; Stefka Kaloianova; Nedyalko Lesev
Journal:  J Fluoresc       Date:  2011-02-22       Impact factor: 2.217

Review 5.  Will nanotechnology influence targeted cancer therapy?

Authors:  Jan Grimm; David A Scheinberg
Journal:  Semin Radiat Oncol       Date:  2011-04       Impact factor: 5.934

Review 6.  Exploiting dendrimer multivalency to combat emerging and re-emerging infectious diseases.

Authors:  Meredith A Mintzer; Eric L Dane; George A O'Toole; Mark W Grinstaff
Journal:  Mol Pharm       Date:  2011-12-13       Impact factor: 4.939

Review 7.  The transferrin receptor and the targeted delivery of therapeutic agents against cancer.

Authors:  Tracy R Daniels; Ezequiel Bernabeu; José A Rodríguez; Shabnum Patel; Maggie Kozman; Diego A Chiappetta; Eggehard Holler; Julia Y Ljubimova; Gustavo Helguera; Manuel L Penichet
Journal:  Biochim Biophys Acta       Date:  2011-08-05

8.  Improvement of the pharmacokinetics and in vivo antibacterial efficacy of a novel type IIa topoisomerase inhibitor by formulation in liposomes.

Authors:  Adam B Shapiro; Joseph Newman; Kosalaram Goteti; Marie-Eve Beaudoin; Rane Harrison; Sussie Hopkins; Nikunj Agrawal; Olga Rivin
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

9.  Self-Assembled Nanospheres for Encapsulation and Aerosolization of Rifampicin.

Authors:  Aline A Ishikawa; Jesus V Salazar; Magaly Salinas; Cristiane M Gaitani; Timothy Nurkiewicz; George R Negrete; Carlos D Garcia
Journal:  RSC Adv       Date:  2016-01-26       Impact factor: 3.361

10.  Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia.

Authors:  Hui Xin Ong; Daniela Traini; David Cipolla; Igor Gonda; Mary Bebawy; Helen Agus; Paul M Young
Journal:  Pharm Res       Date:  2012-07-26       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.